Cite
402. Breakthrough Pneumocystis jirovecii Pneumonia Among Cancer Patients: Opportunity for Antimicrobial Stewardship?
MLA
Catherine Liu, et al. “402. Breakthrough Pneumocystis Jirovecii Pneumonia Among Cancer Patients: Opportunity for Antimicrobial Stewardship?” Open Forum Infectious Diseases, vol. 5, Nov. 2018, pp. S154–55. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ea29318691b30d94c8d011b4c431ebae&authtype=sso&custid=ns315887.
APA
Catherine Liu, Steven Roncaioli, Erica Stohs, Ania Sweet, Andrew Bryan, & Steven A. Pergam. (2018). 402. Breakthrough Pneumocystis jirovecii Pneumonia Among Cancer Patients: Opportunity for Antimicrobial Stewardship? Open Forum Infectious Diseases, 5, S154–S155.
Chicago
Catherine Liu, Steven Roncaioli, Erica Stohs, Ania Sweet, Andrew Bryan, and Steven A. Pergam. 2018. “402. Breakthrough Pneumocystis Jirovecii Pneumonia Among Cancer Patients: Opportunity for Antimicrobial Stewardship?” Open Forum Infectious Diseases 5 (November): S154–55. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ea29318691b30d94c8d011b4c431ebae&authtype=sso&custid=ns315887.